# A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans

> **NCT02360371** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 100 (actual)

## Conditions studied

- Opioid Sensitivity
- Individual Difference
- Abuse Opioids

## Interventions

- **DRUG:** Within-subject test of blinded study medication

## Key facts

- **NCT ID:** NCT02360371
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2020-05
- **Final completion:** 2021-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02360371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02360371, "A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02360371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*